from Reuters: Health News https://ift.tt/2nPZpq4
via IFTTT
Monday, September 30, 2019
AstraZeneca, Merck cancer treatment attains meaningful improvement in progression-free survival
AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.
from Reuters: Health News https://ift.tt/2nPZpq4
via IFTTT
from Reuters: Health News https://ift.tt/2nPZpq4
via IFTTT
0 comments:
Post a Comment